Abstract:BACKGROUND AND AIMS: Syndromic biliary atresia is a cholangiopathy characterized by fibro-obliterative changes in the extrahepatic bile duct (EHBD) and congenital malformations including laterality defects. The aetiology remains elusive and faithful animal models are lacking. Genetic syndromes provide important clues for underlying pathogenic mechanisms of disease. We investigated the role of the gene Pkd1l1 in syndromic biliary atresia pathophysiology.METHODS: Constitutive and conditional Pkd1l1 knockout mice were generated to explore genetic pathology as a cause of syndromic biliary atresia. We assessed for congenital malformations, EHBD and liver pathology, EHBD gene expression, and biliary epithelial cell turnover. Biliary drainage was functionally assessed with cholangiography. Histology and serum chemistries were assessed after 3,5-diethoxycarbony l-1,4-dihydrocollidine (DDC) diet treatment and inhibition of the ciliary signalling effector GLI1.RESULTS: Pkd1l1-deficient mice exhibited congenital anomalies including malrotation and heterotaxy. Pkd1l1-deficient EHBD were hypertrophic and fibrotic. Pkd1l1-deficient EHBD were patent, but displayed delayed biliary drainage. Pkd1l1-deficient livers exhibited ductular reaction and periportal fibrosis. After DDC treatment, Pkd1l1-deficient mice exhibited EHBD obstruction and advanced liver fibrosis. Pkd1l1-deficient mice had increased expression of fibrosis and extracellular matrix remodeling genes (Tgfα, Cdkn1a, Hb-egf, Fgfr3, Pdgfc, Mmp12, and Mmp15) and decreased expression of genes mediating ciliary signalling (Gli1, Gli2, Ptch1, and Ptch2). Primary cilia were reduced on biliary epithelial cells and altered expression of ciliogenesis genes occurred in Pkd1l1-deficient mice. Small molecule inhibition of the ciliary signalling effector GLI1 with Gant61 recapitulated Pkd1l1-deficiency.CONCLUSIONS: Pkd1l1 loss causes both laterality defects and fibro-proliferative EHBD transformation through disrupted ciliary signalling, phenocopying syndromic biliary atresia. Pkd1l1-deficient mice function as an authentic genetic model to study biliary atresia pathogenesis.IMPACT AND IMPLICATIONS: The syndromic form of biliary atresia is characterized by fibro-obliteration of extrahepatic bile ducts and is often accompanied by laterality defects. The aetiology is unknown, but Pkd1l1 was identified as a potential genetic candidate for syndromic biliary atresia. We found that loss of the ciliary gene Pkd1l1 contributes to hepatobiliary pathology in biliary atresia, exhibited by bile duct hypertrophy, reduced biliary drainage, and liver fibrosis in Pkd1l1-deficient mice. Pkd1l1-deficient mice serve as a genetic model of biliary atresia and reveals ciliopathy as an aetiology of biliary atresia. This model will help scientists uncover new therapeutic approaches for patients with biliary atresia and validate screening for PKD1L1 variants by paediatric hepatologists for diagnostic evaluation.

Activation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease

Caroli's Disease: Current Knowledge of Its Biliary Pathogenesis Obtained from an Orthologous Rat Model

Activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat.

Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease

Biliary Infection May Exacerbate Biliary Cystogenesis Through the Induction of Vegf in Cholangiocytes of the Polycystic Kidney (pck) Rat

Notch‐Hes1 signaling activation in Caroli disease and polycystic liver disease

Myocardin-Related Transcription Factor Mediates Epithelial Fibrogenesis in Polycystic Kidney Disease

Myocardin-related transcription factor drives epithelial fibrogenesis in polycystic kidney disease

The Mitogen-Activated Protein Kinase ERK5 Regulates the Development and Growth of Hepatocellular Carcinoma.

β-Catenin-NFkB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction

TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5

Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis

Pkd1l1-deficiency drives biliary atresia through ciliary dysfunction in biliary epithelial cells

The Mechanism of Extracellular Signal-Regulated Kinasesin Formation of Liver Fibrosis in Rats

Keap1 Deletion Accelerates Mutant K-ras/p53-driven Cholangiocarcinoma.

Liver-restricted deletion of the biliary atresia candidate gene Pkd1l1 causes bile duct dysmorphogenesis and ciliopathy

Bile Acid Exposure Up-Regulates Tuberous Sclerosis Complex 1/mammalian Target of Rapamycin Pathway in Barrett'S-Associated Esophageal Adenocarcinoma

Conditional Mutation of Pkd2 Causes Cystogenesis and Upregulates Beta-Catenin.

Molecular Validation of the Precision-Cut Kidney Slice (PCKS) Model of Renal Fibrosis Through Assessment of TGF-β1-induced Smad and P38/erk Signaling.

<i>Keap1</i> deletion accelerates mutant <i>K-ras</i>/<i>p53</i>-driven cholangiocarcinoma

Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1-/- mouse model of congenital hepatic fibrosis